BCL2 and hepatocellular carcinoma: Luteolin also been reported to induce apoptosis in other types of cancer cells (such as, hepatocellular carcinoma cells, colorectal cancer cells and pancreatic carcinoma cells) through activating Casepase-3, increasing Bax and decreasing BCL-2 protein expression levels (40-42).